Prestige Consumer Healthcare (PBH) Net Cash Flow Growth (1y) (2011 - 2025)
Prestige Consumer Healthcare (PBH) Net Cash Flow Growth (1y) (2011 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | -117.27% |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | -167.84% |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | -290.21% |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 270.63% |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | -367.42% |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | -7.60% |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 272.00% |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Prestige Consumer Healthcare | 2.43 Bn | 2.36 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -4,142.91% |
| Sep 30, 2025 | -223.04% |
| Jun 30, 2025 | 416.81% |
| Mar 31, 2025 | 383.42% |
| Dec 31, 2024 | -33.90% |
| Sep 30, 2024 | 177.28% |
| Jun 30, 2024 | -241.63% |
| Mar 31, 2024 | 40.64% |
| Dec 31, 2023 | -95.05% |
| Sep 30, 2023 | -17.08% |
| Jun 30, 2023 | -138.36% |
| Mar 31, 2023 | -587.34% |
| Dec 31, 2022 | 299.90% |
| Sep 30, 2022 | 106.01% |
| Jun 30, 2022 | -92.54% |
| Mar 31, 2022 | 119.37% |
| Dec 31, 2021 | -162.60% |
| Sep 30, 2021 | -272.12% |
| Jun 30, 2021 | 439.60% |
| Mar 31, 2021 | -143.14% |